E2 ModeratePreliminaryPEM unclearCase-ControlPeer-reviewedMachine draft
Persistence of enterovirus RNA in muscle biopsy samples suggests that some cases of chronic fatigue syndrome result from a previous, inflammatory viral myopathy.
Bowles, N E, Bayston, T A, Zhang, H Y et al. · Journal of medicine · 1993
Quick Summary
Researchers tested muscle samples from people with post-viral fatigue syndrome (a condition similar to ME/CFS that develops after a viral infection) and found evidence of enterovirus RNA in about 26% of samples. This was much higher than in healthy control samples. The study suggests that some cases of ME/CFS may develop after a viral infection causes inflammation in the muscles, similar to how viral heart infections can lead to long-term heart problems.
Why It Matters
This study provides molecular evidence that some ME/CFS cases may have a viral origin, specifically persistence of enterovirus in muscle tissue. Understanding the pathophysiology of post-viral fatigue could help develop better diagnostic markers and targeted treatments, and validates the experience of patients whose illness began after a clear viral infection.
Observed Findings
- Enterovirus RNA detected in 41 of 158 (26%) postviral fatigue syndrome muscle biopsy samples
- Enterovirus RNA detected in only 2 of 152 (1.3%) control muscle samples
- Enterovirus RNA detected in 25 of 96 (26%) inflammatory muscle disease samples
- Muscle histology in PFS group was normal or showed only non-specific changes, unlike inflammatory myopathy group which showed infiltration and fiber necrosis
Inferred Conclusions
- Some cases of postviral fatigue syndrome may result from persistent enteroviral infection in muscle tissue following an acute inflammatory viral myopathy
- The presence of enterovirus RNA in muscle correlates with post-viral fatigue more than with control samples
- Post-viral fatigue syndrome may be analogous to post-viral myocarditis, where viral persistence leads to long-term dysfunction despite resolution of acute inflammation
Remaining Questions
- What proportion of ME/CFS cases have enterovirus persistence versus other viral or infectious agents?
- Does the presence of enterovirus RNA correlate with symptom severity or specific symptom profiles in ME/CFS patients?
- How long does enterovirus RNA persist in muscle tissue, and does it indicate active viral replication or latency?
What This Study Does Not Prove
This study does not prove that all ME/CFS cases are caused by enterovirus persistence, as only about one-quarter of PFS samples tested positive. Detecting viral RNA does not establish that it is causing current symptoms or that it is replicating rather than simply persisting. The cross-sectional design cannot establish causation or the timeline of infection relative to symptom onset.
Tags
Symptom:Fatigue
Biomarker:Gene Expression
Phenotype:Infection-Triggered
Method Flag:PEM Not DefinedWeak Case DefinitionExploratory Only
Metadata
- PMID
- 8409778
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →